Editorial About: “A Prospective, Open-Label, Multicenter Phase II Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma”
Crossref DOI link: https://doi.org/10.1245/s10434-019-07737-6
Published Online: 2019-08-22
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schwartz, Patrick B.
Uboha, Nataliya V.
Weber, Sharon M.
Text and Data Mining valid from 2019-08-22
Version of Record valid from 2019-08-22
Article History
Received: 31 July 2019
First Online: 22 August 2019
Free to read: This content has been made available to all.